TELA Bio, Inc. (TELA) Misses Q2 EPS by 4c

TELA Bio, Inc. (NASDAQ: TELA) reported Q2 EPS of ($0.22), $0.04 worse than the analyst estimate of ($0.18). Revenue for the quarter came in at $20.2 million versus the consensus estimate of $20.67 million.

For earnings history and earnings-related data on TELA Bio, Inc. (TELA) click here.

You May Also Be Interested In

• Etsy upgraded to buy at BofA on durable growth, buyback potential
• Advance Auto Parts falls on revenue miss, weak guidance
• Nlight (LASR) Reiterated at Buy by Stifel: Sell-off is a 'Buying Opportunity'